Correlation Between Kiora Pharmaceuticals and SAB Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Kiora Pharmaceuticals and SAB Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kiora Pharmaceuticals and SAB Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kiora Pharmaceuticals and SAB Biotherapeutics, you can compare the effects of market volatilities on Kiora Pharmaceuticals and SAB Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kiora Pharmaceuticals with a short position of SAB Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kiora Pharmaceuticals and SAB Biotherapeutics.
Diversification Opportunities for Kiora Pharmaceuticals and SAB Biotherapeutics
0.08 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Kiora and SAB is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Kiora Pharmaceuticals and SAB Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SAB Biotherapeutics and Kiora Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kiora Pharmaceuticals are associated (or correlated) with SAB Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SAB Biotherapeutics has no effect on the direction of Kiora Pharmaceuticals i.e., Kiora Pharmaceuticals and SAB Biotherapeutics go up and down completely randomly.
Pair Corralation between Kiora Pharmaceuticals and SAB Biotherapeutics
Given the investment horizon of 90 days Kiora Pharmaceuticals is expected to generate 0.19 times more return on investment than SAB Biotherapeutics. However, Kiora Pharmaceuticals is 5.29 times less risky than SAB Biotherapeutics. It trades about -0.08 of its potential returns per unit of risk. SAB Biotherapeutics is currently generating about -0.14 per unit of risk. If you would invest 391.00 in Kiora Pharmaceuticals on November 18, 2024 and sell it today you would lose (29.00) from holding Kiora Pharmaceuticals or give up 7.42% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 95.24% |
| Values | Daily Returns |
Kiora Pharmaceuticals vs. SAB Biotherapeutics
Performance |
| Timeline |
| Kiora Pharmaceuticals |
| SAB Biotherapeutics |
Kiora Pharmaceuticals and SAB Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kiora Pharmaceuticals and SAB Biotherapeutics
The main advantage of trading using opposite Kiora Pharmaceuticals and SAB Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kiora Pharmaceuticals position performs unexpectedly, SAB Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SAB Biotherapeutics will offset losses from the drop in SAB Biotherapeutics' long position.| Kiora Pharmaceuticals vs. Virax Biolabs Group | Kiora Pharmaceuticals vs. Revelation Biosciences | Kiora Pharmaceuticals vs. Quoin Pharmaceuticals Ltd | Kiora Pharmaceuticals vs. Allarity Therapeutics |
| SAB Biotherapeutics vs. SAB Biotherapeutics | SAB Biotherapeutics vs. Jasper Therapeutics | SAB Biotherapeutics vs. NRx Pharmaceuticals | SAB Biotherapeutics vs. Surrozen Warrant |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |